Status:
COMPLETED
Technology and Health Communication in Improving Health Outcomes in Patients Scheduled for Mammography
Lead Sponsor:
Fox Chase Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Female Breast Carcinoma
Healthy Subject
Eligibility:
FEMALE
Phase:
NA
Brief Summary
This pilot clinical trial studies how well technology and health communication works in improving health outcomes in patients scheduled for mammography screening. The Mobile Mammography Screening Prog...
Detailed Description
PRIMARY OBJECTIVES: I. To decrease the mobile mammography unit no-show rate by sending text message appointment reminders to patients. II. To assess the efficacy of the text message reminders at add...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Appointment is at a participating location
- Has a cell phone that can send and receive text messages
- Agrees to receive the text messages
- Can read either English or Spanish
- Not yet sent text messages to 100 patients in community or corporate sites
- Scheduled at least 1 week prior to the appointment date
- PATIENTS FOR FOLLOW UP: come to their scheduled appointment
- PATIENTS FOR FOLLOW UP: received the text message reminders
- PATIENTS FOR FOLLOW UP: can read either English or Spanish
Exclusion
Key Trial Info
Start Date :
March 5 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2017
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04290585
Start Date
March 5 2014
End Date
October 1 2017
Last Update
March 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111